Recurrent or Metastatic, Platinum-refractory Cervical Cancer
1 clinical trials · Condition
◉ Watch Recurrent or Metastatic, Platinum-refractory Cervical Cancer
| Record | Firm | Date |
|---|---|---|
| Study of Cemiplimab in Adults With Cervical Cancer (NCT03257267) | Regeneron Pharmaceuticals | 2017-09-05 |
Track Recurrent or Metastatic, Platinum-refractory Cervical Cancer automatically
Every clearance here is in the API, with alerts when new ones post.